IFN-β provides immuno-protection in the retina by inhibiting ICAM-1 and CXCL9 in retinal pigment epithelial cells

Journal of Immunology

Volumn 180, Issue 6, 2008, Pages 3789-3796

  Hooks, John J ^a   Nagineni, Chandrasekharam N ^a   Hooper, Laura C ^a   Hayashi, Kozaburo ^a   Detrick, Barbara ^b  

^a NATIONAL EYE INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON REGULATORY FACTOR 7; AUTACOID; CXCL10 PROTEIN, HUMAN; CXCL9 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; EYE PROTECTION; GENE EXPRESSION; HUMAN; HUMAN CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; DNA MICROARRAY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; IMMUNOLOGY; KINETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RETINITIS; SECRETION; VESICULAR STOMATITIS VIRUS; VIROLOGY;

CELLS, CULTURED; CHEMOKINE CXCL10; CHEMOKINE CXCL9; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-BETA; KINETICS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PIGMENT EPITHELIUM OF EYE; RETINITIS; VESICULAR STOMATITIS INDIANA VIRUS;

EID: 44849119832     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.6.3789     Document Type: Article

References (57)

1. Isaacs, A., and J. Lindenmann. 1957. Virus interference: I. The interferon. Proc. R. Soc. Lond. B Biol. Sci. 147: 258-267.
2. Pestka, S., C. D. Krause, and M. R. Walter. 2004. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202: 8-32.
3. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
4. Panitch, H., D. S. Goodin, G. Francis, P. Chang, P. K. Coyle, P. O'Connor, E. Monaghan, D. Li, and B. Weinshenker. 2002. Randomized, comparative study of interferon β-1a treatment regimens in MS: the EVIDENCE trial. Neurology 59: 1496-1506.
5. Bok, D. 1993. The retinal pigment epithelium: a versatile partner in vision. J. Cell Sci. (Suppl. 17): 189-195.
6. Hamel, C. P., E. Tsilou, B. A. Pfeffer, J. J. Hooks, B. Detrick, and T. M. Redmond. 1993. Molecular cloning and expression of RPE65, a novel retinal pigment epithelium-specific microsomal protein that is post-transcriptionally regulated in vitro. J. Biol. Chem. 268: 15751-15757.
7. Morimura, H., G. A. Fishman, S. A. Grover, A. B. Fulton, E. L. Berson, and T. P. Dryja. 1998. Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis. Proc. Natl. Acad. Sci. USA 95: 3088-3093.
8. Morimura, H., F. Saindelle-Ribeaudeau, E. L. Berson, and T. P. Dryja. 1999. Mutations in RGR, encoding a light-sensitive opsin homologue, in patients with retinitis pigmentosa. Nat. Genet. 23: 393-394.
9. Lutty, G., J. Grunwald, A. B. Majji, M. Uyama, and S. Yoneya. 1999. Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration. Mol. Vis. 5: 35.
10. Cai, J., K. C. Nelson, M. Wu, P. Sternberg, Jr., and D. P. Jones. 2000. Oxidative damage and protection of the RPE. Prog. Retin. Eye Res. 19: 205-221.
11. Detrick, B., J. Rhame, Y. Wang, C. N. Nagineni, and J. J. Hooks. 1996. Cytomegalovirus replication in human retinal pigment epithelial cells: altered expression of viral early proteins. Invest. Ophthalmol. Visual Sci. 37: 814-825.
12. Detrick, B., C. N. Nagineni, L. R. Grillone, K. P. Anderson, S. P. Henry, and J. J. Hooks. 2001. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides. Invest. Ophthalmol. Visual Sci. 42: 163-169.
13. Hooks, J. J., M. S. Chin, K. Srinivasan, Y. Momma, L. C. Hooper, C. N. Nagineni, C. C. Chan, and B. Detrick. 2006. Human cytomegalovirus induced cyclooxygenase-2 in human retinal pigment epithelial cells augments viral replication through a prostaglandin pathway. Microbes Infect. 8: 2236-2244.
14. Hooks, J. J., C. Percopo, Y. Wang, and B. Detrick. 1993. Retina and retinal pigment epithelial cell autoantibodies are produced during murine coronavirus retinopathy. J. Immunol. 151: 3381-3389.
15. Nagineni, C. N., B. Detrick, and J. J. Hooks. 2000. Toxoplasma gondii infection induces gene expression and secretion of interleukin 1 (IL-1), IL-6, granulocyte-macrophage colony-stimulating factor, and intercellular adhesion molecule 1 by human retinal pigment epithelial cells. Infect. Immun. 68: 407-410.
16. Chin, M. S., C. N. Nagineni, L. C. Hooper, B. Detrick, and J. J. Hooks. 2001. Cyclooxygenase-2 gene expression and regulation in human retinal pigment epithelial cells. Invest. Ophthalmol. Visual Sci. 42: 2338-2346.
17. Momma, Y., C. N. Nagineni, M. S. Chin, K. Srinivasan, B. Detrick, and J. J. Hooks. 2003. Differential expression of chemokines by human retinal pigment epithelial cells infected with cytomegalovirus. Invest. Ophthalmol. Visual Sci. 44: 2026-2033.
18. Percopo, C. M., J. J. Hooks, T. Shinohara, R. Caspi, and B. Detrick. 1990. Cytokine-mediated activation of a neuronal retinal resident cell provokes antigen presentation. J. Immunol. 145: 4101-4107.
19. Medzhitov, R., and C. A. Janeway, Jr. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91: 295-298.
20. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
21. Kumar, M. V., C. N. Nagineni, M. S. Chin, J. J. Hooks, and B. Detrick. 2004. Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells. J. Neuroimmunol. 153: 7-15.
22. Lafon, M., C. Prehaud, F. Megret, M. Lafage, G. Mouillot, M. Roa, P. Moreau, N. Rouas-Freiss, and E. D. Carosella. 2005. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J. Virol. 79: 15226-15237.
23. Ritter, M., D. Mennerich, A. Weith, and P. Seither. 2005. Characterization of Toll-like receptors in primary lung epithelial cells: strong impact of the TLR ligand poly(I:C) on the regulation of Toll-like receptors, adaptor proteins and inflammatory response. J. Inflamm. 2: 16.
24. Prehaud, C., F. Megret, M. Lafage, and M. Lafon. 2005. Virus infection switches TLR-3-positive human neurons to become strong producers of β interferon. J. Virol. 79: 12893-12904.
25. Nagineni, C. N., K. S. Cherukuri, V. Kutty, B. Detrick, and J. J. Hooks. 2007. Interferon-γ differentially regulates TGF-β1 and TGF-β2 expression in human retinal pigment epithelial cells through JAK-STAT pathway. J. Cell. Physiol. 210: 192-200.
26. Hooks, J. J., B. Detrick, C. Percopo, C. Hamel, and R. P. Siraganian. 1989. Development and characterization of monoclonal antibodies directed against the retinal pigment epithelial cell. Invest. Ophthalmol. Visual Sci. 30: 2106-2113.
27. Osterlund, P. I., T. E. Pietila, V. Veckman, S. V. Kotenko, and I. Julkunen. 2007. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-λ) genes. J. Immunol. 179: 3434-3442.
28. Sato, M., N. Hata, M. Asagiri, T. Nakaya, T. Taniguchi, and N. Tanaka. 1998. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett. 441: 106-110.
29. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777.
30. Nagineni, C. N., R. K. Kutty, B. Detrick, and J. J. Hooks. 1996. Inflammatory cytokines induce intercellular adhesion molecule-1 (ICAM-1) mRNA synthesis and protein secretion by human retinal pigment epithelial cell cultures. Cytokine 8: 622-630.
31. Takaoka, A., and T. Taniguchi. 2003. New aspects of IFN-αβ signalling in immunity, oncogenesis and bone metabolism. Cancer Sci. 94: 405-411.
32. Taniguchi, T., and A. Takaoka. 2002. The interferon-αβ system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 14: 111-116.
33. Hayashi, K., L. C. Hooper, M. S. Chin, C. N. Nagineni, B. Detrick, and J. J. Hooks. 2006. Herpes simplex virus 1 (HSV-1) DNA and immune complex (HSV-1-human IgG) elicit vigorous interleukin 6 release from infected corneal cells via Toll-like receptors. J. Gen. Virol. 87: 2161-2169.
34. Der, S. D., A. Zhou, B. R. Williams, and R. H. Silverman. 1998. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95: 15623-15628.
35. Yamazaki, K., K. Suzuki, E. Yamada, T. Yamada, F. Takeshita, M. Matsumoto, T. Mitsuhashi, T. Obara, K. Takano, and K. Sato. 2007. Suppression of iodide uptake and thyroid hormone synthesis with stimulation of the type I interferon system by double-stranded RNA (dsRNA) in cultured human thyroid follicles. Endocrinology 148: 3226-3235.
36. Zou, W., J. H. Kim, A. Handidu, X. Li, K. I. Kim, M. Yan, J. Li, and D. E. Zhang. 2007. Microarray analysis reveals that Type I interferon strongly increases the expression of immune-response related genes in Ubp43 (Usp18) deficient macrophages. Biochem. Biophys. Res. Commun. 356: 193-199.
37. Kawada, J., H. Kimura, Y. Kamachi, K. Nishikawa, M. Taniguchi, K. Nagaoka, H. Kurahashi, S. Kojima, and T. Morishima. 2006. Analysis of gene-expression profiles by oligonucleotide microarray in children with influenza. J. Gen. Virol. 87: 1677-1683.
38. Lang, K. S., P. Georgiev, M. Recher, A. A. Navarini, A. Bergthaler, M. Heikenwalder, N. L. Harris, T. Junt, B. Odermatt, P. A. Clavien, et al. 2006. Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J. Clin. Invest. 116: 2456-2463.
39. Bhutto, I. A., D. S. McLeod, C. Merges, T. Hasegawa, and G. A. Lutty. 2006. Localisation of SDF-1 and its receptor CXCR4 in retina and choroid of aged human eyes and in eyes with age related macular degeneration. Br. J. Ophthalmol. 90: 906-910.
40. Lima e Silva, R., J. Shen, S. F. Hackett, S. Kachi, H. Akiyama, K. Kiuchi, K. Yokoi, M. C. Hatara, T. Lauer, S. Aslam, et al. 2007. The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization. FASEB J. 21: 3219-3230.
41. Kamei, M., and J. G. Hollyfield. 1999. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. Invest. Ophthalmol. Visual Sci. 40: 2367-2375.
42. Bergelson, J. M., J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. S. Hong, M. S. Horwitz, R. L. Crowell, and R. W. Finberg. 1997. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275: 1320-1323.
43. Zen, K., Y. Liu, I. C. McCall, T. Wu, W. Lee, B. A. Babbin, A. Nusrat, and C. A. Parkos. 2005. Neutrophil migration across tight junctions is mediated by adhesive interactions between epithelial coxsackie and adenovirus receptor and a junctional adhesion molecule-like protein on neutrophils. Mol. Biol. Cell 16: 2694-2703.
44. Dorrell, M. I., E. Aguilar, L. Scheppke, F. H. Barnett, and M. Friedlander. 2007. Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis. Proc. Natl. Acad. Sci. USA 104: 967-972.
45. Luster, A. D., R. Alon, and U. H. von Andrian. 2005. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6: 1182-1190.
46. + T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection. Cell. Immunol. 243: 83-89.
47. Khan, I. A., J. A. MacLean, F. S. Lee, L. Casciotti, E. DeHaan, J. D. Schwartzman, and A. D. Luster. 2000. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12: 483-494.
48. Christen, U., D. B. McGavern, A. D. Luster, M. G. von Herrath, and M. B. Oldstone. 2003. Among CXCR3 chemokines, IFN-γ-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-γ (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J. Immunol. 171: 6838-6845.
49. Salomon, I., N. Netzer, G. Wildbaum, S. Schif-Zuck, G. Maor, and N. Karin. 2002. Targeting the function of IFN-γ-inducible protein 10 suppresses ongoing adjuvant arthritis. J. Immunol. 169: 2685-2693.
50. Wallace, G. R., S. John Curnow, K. Wloka, M. Salmon, and P. I. Murray. 2004. The role of chemokines and their receptors in ocular disease. Prog. Retin. Eye Res. 23: 435-448.
51. Gorbachev, A. V., H. Kobayashi, D. Kudo, C. S. Tannenbaum, J. H. Finke, S. Shu, J. M. Farber, and R. L. Fairchild. 2007. CXC chemokine ligand 9/monokine induced by IFN-γ production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors. J. Immunol. 178: 2278-2286.
52. Ure, D. R., T. E. Lane, M. T. Liu, and M. Rodriguez. 2005. Neutralization of chemokines RANTES and MIG increases virus antigen expression and spinal cord pathology during Theiler's virus infection. Int. Immunol. 17: 569-579.
53. Su, A. I., J. P. Pezacki, L. Wodicka, A. D. Brideau, L. Supekova, R. Thimme, S. Wieland, J. Bukh, R. H. Purcell, P. G. Schultz, and F. V. Chisari. 2002. Genomic analysis of the host response to hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 99: 15669-15674.
54. Hooks, J. J., Y. Wang, and B. Detrick. 2003. The critical role of IFN-γ in experimental coronavirus retinopathy. Invest. Ophthalmol. Visual Sci. 44: 3402-3408.
55. Detrick, B., M. T. Lee, M. S. Chin, L. C. Hooper, C. C. Chan, and J. J. Hooks. 2008. Experimental coronavirus retinopathy (ECOR): retinal degeneration susceptible mice have an augmented interferon and chemokine (CXCL9, CXCL10) response early after virus infection. J. Neuroimmunol. 193: 28-37.
56. Buttmann, M., and P. Rieckmann. 2007. Interferon-β1b in multiple sclerosis. Expert Rev. Neurother. 7: 227-239.
57. Szczucinski, A., and J. Losy. 2007. Chemokines and chemokine receptors in multiple sclerosis: potential targets for new therapies. Acta Neurol. Scand. 115: 137-146.